Maillard reaction products enriched food extract reduce the expression of myofibroblast phenotype markers

Stefanie Ruhs1, Norbert Nass, Veronika Somoza

  • 1Department of Cardiothoracic Surgery, University of Halle-Wittenberg, Halle, Germany.

Insights

Advanced glycation end products (AGEs) are linked to diseases. This study found that bread crust extract, rich in AGEs, may reduce cardiac fibrosis by decreasing myofibroblast differentiation markers in cardiac fibroblasts.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Nutritional Science

Background:

  • Advanced glycation end products (AGEs) are implicated in various degenerative diseases.
  • Cardiac fibroblasts (CFs) play a crucial role in cardiac fibrosis, a key process in heart disease.
  • Nutritional interventions targeting AGEs are being explored for therapeutic potential.

Purpose of the Study:

  • To investigate the impact of AGE-containing nutritional extracts on cardiac fibroblasts.
  • To determine if bread crust extract (BCE), a source of AGEs, influences cardiac fibrosis markers.

Main Methods:

  • Primary mouse cardiac fibroblasts (CFs) were treated with varying concentrations of BCE.
  • Cell viability, reactive oxygen species (ROS) production, and key signaling pathways (MAPK, NF-kappaB, Akt) were assessed.
  • Expression of myofibroblast differentiation markers (smooth muscle alpha-actin, tropomyosin-1) was analyzed.

Main Results:

  • BCE treatment up to 30 mg/mL did not affect CF viability.
  • BCE moderately increased ROS production and activated redox-sensitive pathways (p42/44 MAPK, p38 MAPK, NF-kappaB).
  • BCE treatment significantly reduced the expression of myofibroblast differentiation markers.

Conclusions:

  • Melanoidin-rich food components, like those in BCE, may possess antifibrotic properties.
  • The findings suggest a potential role for dietary AGEs in modulating cardiac fibrosis.
  • Further research is warranted to elucidate the precise mechanisms and therapeutic applications.

Related Concept Videos